A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027)

Phase 1 Completed 146 enrolled Merck Sharp & Dohme LLC

RandomizedParallel-groupOpen-labelBasic science

Summary

The goal of the study is to learn what happens to different forms of sotatercept medications in a healthy person's body over time. Researchers want to know if there is a difference in the healthy person's body when different forms of sotatercept medications are given.

Timeline

Start: 2025-05-16
Primary completion: 2025-11-11
Completion: 2025-11-25

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Sotatercept	Protein / enzyme biologic	—	Subcutaneous

Indications

No indication recorded.